BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BL-M24D1 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BL-M24D1\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07232524-2401@assetmemo.bio
DTSTAMP:20261121T005431Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:BL-M24D1: Phase 1 readout est. (NCT07232524)
DESCRIPTION:BL-M24D1\, phase 1.\nStudy: A Study of BL-M24D1 in Patients Wit
 h Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and
  Other Solid Tumors\nEstimated primary completion: November 2027. This is 
 a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can 
 move.\nDrug page: https://assetmemo.bio/drug/bl-m24d1#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07232524
URL:https://assetmemo.bio/drug/bl-m24d1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07232420-2401@assetmemo.bio
DTSTAMP:20261121T005431Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:BL-M24D1: Phase 1 readout est. (NCT07232420)
DESCRIPTION:BL-M24D1\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Stud
 y of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Ce
 ll Lung Cancer and Other Solid Tumors\nEstimated primary completion: Decem
 ber 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/bl-m24d1#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT072324
 20
URL:https://assetmemo.bio/drug/bl-m24d1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07279428-2401@assetmemo.bio
DTSTAMP:20261121T005431Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:BL-M24D1: Phase 1 readout est. (NCT07279428)
DESCRIPTION:BL-M24D1\, phase 1.\nStudy: A Study of BL-M24D1 in Patients Wit
 h Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid T
 umors\nEstimated primary completion: December 2027. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/bl-m24d1#upcoming-events\nRegistry record: 
 https://clinicaltrials.gov/study/NCT07279428
URL:https://assetmemo.bio/drug/bl-m24d1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07255898-2401@assetmemo.bio
DTSTAMP:20261121T005431Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:BL-M24D1: Phase 1 readout est. (NCT07255898)
DESCRIPTION:BL-M24D1\, phase 1.\nStudy: A Study of BL-M24D1 in Patients Wit
 h Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignanci
 es\nEstimated primary completion: December 2027. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/bl-m24d1#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT07255898
URL:https://assetmemo.bio/drug/bl-m24d1#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
